Adjuvant trastuzumab and vinorelbine for early-stage HER2+ breast cancer.

Shannon McLaughlin,Erika Nakajima,Yael Bar,Jennifer A Hutchinson,Jennifer Shin,Beverly Moy,Steven J Isakoff,Aditya Bardia,Irene Kuter,Laura M Spring

Therapeutic advances in medical oncology（2023）

引用 0|浏览16

暂无评分

摘要

Trastuzumab in combination with vinorelbine in the adjuvant, early-stage setting for low-risk HER2+ BC demonstrated clinical efficacy and appeared to be well tolerated. TV warrants further evaluation as an alternative regimen to TH for patients with early-stage HER2+ BC.

查看译文

关键词

HER2+ breast cancer,HER2-targeted therapy,adjuvant therapy,breast cancer,chemotherapy

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要